Document Type
Review
Publication Date
8-1-2012
Keywords
Cardiovascular disease, Dietary supplement, Docosahexaenoic acid, Eicosapentaenoic acid, Fish oil, Metabolic syndrome, Obesity
Digital Object Identifier (DOI)
https://doi.org/10.1517/17460441.2012.694862
Abstract
Introduction: During the early 1970s, Danish physicians Jorn Dyerberg and colleagues observed that Greenland Eskimos consuming fatty fishes exhibited low incidences of heart disease. Fish oil is now one of the most commonly consumed dietary supplements. In 2004, concentrated fish oil was approved as a drug by the FDA for the treatment of hyperlipidemia. Fish oil contains two major omega-3 fatty acids: eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). With advancements in lipid concentration and purification techniques, EPA- or DHA-enriched products are now commercially available, and the availability of these components in isolation allows their individual effects to be examined. Newly synthesized derivatives and endogenously discovered metabolites of DHA exhibit therapeutic utility for obesity, metabolic syndrome and cardiovascular disease. Areas covered: This review summarizes our current knowledge on the distinct effects of EPA and DHA to prevent metabolic syndrome and reduce cardiotoxicity risk. Since EPA is an integral component of fish oil, we will briefly review EPA effects, but our main theme will be to summarize effects of the DHA derivatives that are available today. We focus on using nutrition-based drug discovery to explore the potential of DHA derivatives for the treatment of obesity, metabolic syndrome and cardiovascular diseases. Expert opinion: The safety and efficacy evaluation of DHA derivatives will provide novel biomolecules for the drug discovery arsenal. Novel nutritional-based drug discoveries of DHA derivatives or metabolites may provide realistic and alternative strategies for the treatment of metabolic and cardiovascular disease.
Rights Information
Was this content written or created while at USF?
No
Citation / Publisher Attribution
Expert Opinion on Drug Discovery, v. 7, issue 8, p. 711-721
This is an Accepted Manuscript of an article published by Taylor & Francis in Expert Opinion on Drug Discovery on 24 June 2012, available online: http://www.tandfonline.com/10.1517/17460441.2012.694862
Scholar Commons Citation
Ma, Yonggang; Lindsey, Merry L.; and Halade, Ganesh V., "Dha Derivatives of Fish Oil as Dietary Supplements: a Nutrition-Based Drug Discovery Approach for Therapies to Prevent Metabolic Cardiotoxicity" (2012). Internal Medicine Faculty Publications. 64.
https://digitalcommons.usf.edu/intmed_facpub/64
